3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jamieson, GP; Snook, MB; Thurlow, PJ; Wiley, JS | 1 |
Cornish, JE; Gargett, CE; Wiley, JS | 1 |
Bendall, LJ; Gu, B; Wiley, JS | 1 |
Gargett, CE; Jamieson, GP; Snook, MB; Wiley, JS; Zhang, W | 1 |
Bendall, LJ; Buell, GN; Chessell, IP; Gu, BJ; Wiley, JS; Zhang, WY | 1 |
5 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters.
Topics: Adenosine Triphosphate; Alkaloids; Calcium; Cells, Cultured; Down-Regulation; Humans; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Magnesium; Protein Kinase C; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1996 |
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides | 1997 |
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
Topics: Adenosine Triphosphate; B-Lymphocytes; Biomarkers, Tumor; Calcium; Humans; Hydroxamic Acids; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloendopeptidases; Neoplasm Proteins; Neoplastic Stem Cells; Protease Inhibitors; Receptors, IgE; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Solubility; Tetradecanoylphorbol Acetate | 1998 |
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
Topics: Adenosine Triphosphate; B-Lymphocytes; Barium; Calcium; Cell Membrane Permeability; Cells, Cultured; Cloning, Molecular; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Macrophages; Monocytes; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides | 1998 |
Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
Topics: Adenosine Triphosphate; Antibodies, Monoclonal; Barium; Blood Platelets; Ethidium; Flow Cytometry; Humans; Intracellular Fluid; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Lymphocytes; Monocytes; Polymerase Chain Reaction; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reference Values; RNA, Messenger | 2000 |